	From pancreatic ductal adenocarcinoma to non-small cell lung cancer: daraxonrasib in the RASolute 302 trial - a pan-RAS(ON) breakthrough or the next evolution in targeting diverse oncogenic RAS variants? Ann Med Surg (Lond) Qaseem M, Ali MS, Ali S, Hasan AH. PMID: 42433811 [PubMed]
	Comparison of dosimetric parameters and delivery accuracy between conformal radiotherapy-intensity modulated radiotherapy-combined and intensity-modulated radiotherapy planning for central lung cancer patients receiving stereotactic body radiotherapy. Quant Imaging Med Surg Shao Y, Guo J, Duan Y, Huang Y, Feng A, Chen H, Wang H, Gu H, Shen Z, Xu Z. PMID: 42433523 [PubMed]
	Quantifying the impact of slice thickness on cardiovascular risk stratification in lung cancer screening: a multi-center "RESCUE" study. Quant Imaging Med Surg Wang M, Zhang J, Zhu R, Gu J, Fan L, Chen Q. PMID: 42433512 [PubMed]
	Efficacy and safety of Programmed Death Ligand 1 inhibitors versus Programmed Death 1 inhibitors in the first-line treatment of advanced non-small cell lung cancer: a meta-analysis of randomized controlled trials. PeerJ Dang C, Li J, Chen H, Luo Z. PMID: 42433386 [PubMed - in process]
	Assessment of tumor mutation burden based on whole-exome sequencing of extracellular vesicle-derived DNA from bronchoalveolar lavage fluid in advanced non-small cell lung cancer treated with pembrolizumab: a prospective, multicenter, observational study. Transl Lung Cancer Res Kim H, Hur J, Kim WS, Kim IA, Park D, Oh IJ, Noh SJ, Bang H, Lee KY. PMID: 42433255 [PubMed]
	Over- and underscreening for lung cancer. Transl Lung Cancer Res Cao H, Zhang Y, Fu F, Chen H. PMID: 42433251 [PubMed]
	Consolidation thoracic radiotherapy following quadruple induction with benmelstobart, anlotinib, and chemotherapy for extensive-stage small cell lung cancer: rationale and protocol of a phase II study. Transl Lung Cancer Res Zhou Y, Zhu H, Yang S, Liu J, Yu M, Sun J, Yang C, Cui Y, Liu N. PMID: 42433250 [PubMed]
	Prognostic analysis and beneficiary population exploration of subsequent treatment regimens after third-generation EGFR-TKIs failure in EGFR-mutated advanced non-small cell lung cancer: a retrospective cohort study. Transl Lung Cancer Res Wu Z, Liu T, Yu R, Li J, Hu S, Liu C, Du X, Shi X, Dai Y, Lu L, Ma Y, Jiang Y, Shi Y, Zhou G, Chen C, Shi J, Ding N, Wang X. PMID: 42433249 [PubMed]
	Inconsistent definitions of radical resection in perioperative trials of non-small cell lung cancer: a scoping review. Transl Lung Cancer Res Niedzielska J, Szczepa, Ciarka A, P, Szylberg , Borowczak J, Marja. PMID: 42433245 [PubMed]
	Ultrasound assessment of pleural invasion via visceral pleura interruption and arch distance-to-tumour diameter ratio in a rabbit model of subpleural lung cancer. Transl Lung Cancer Res Zhang S, Shu M, Lin Y, Zhang Y, Liang G, Chen W, Wei D, He L, Tang Q, Tang J, Yang H. PMID: 42433244 [PubMed]
	Development and validation of a PET/CT radiomics and dual-task learning model for the prediction of pathological subtypes and EGFR mutation in non-small cell lung cancer. Transl Lung Cancer Res Jiang F, Zhang NF, Gao Y, Chen X, Liu ET, Mou T. PMID: 42433241 [PubMed]
	Targeting MET amplification in non-small cell lung cancer: encouraging results with vebreltinib from the phase II KUNPENG study. Transl Lung Cancer Res Urbanska EM, Grauslund M, Sørensen JB, Santoni-Rugiu E. PMID: 42433240 [PubMed]
	Current advances in extended resections for non-small cell lung cancer-a narrative review. Transl Lung Cancer Res Sinn K, Begic M, Hoda MA, Aigner C. PMID: 42433233 [PubMed]
	Computed tomography-based deep learning prediction of radiation-induced functional decline after lung cancer radiotherapy. Transl Lung Cancer Res Kim JC, Kim S, Park JH, Heo J. PMID: 42433232 [PubMed]
	Grading the evidence for CPET variables in predicting perioperative morbidity and long-term mortality in lung cancer surgery: a systematic review and meta-analysis. Syst Rev Dun Y, Yu J, Gao Y, Thomas RJ, Squires RW, Olson TP, Zhang W, Wu S, Du Y, Liu S. PMID: 42432773 [PubMed - as supplied by publisher]
	Lower blood glucose levels (HbA1c) within the non-diabetic range are associated with improved survival in patients diagnosed with lung, colon and ovarian cancer: an explorative study. BMC Cancer Abrahamsen O, Schou JHV, Johansen JS, Jensen MB, Lykke J, Høgdall C, Budtz-Jørgensen E, Høgdall E. PMID: 42432556 [PubMed - as supplied by publisher]
	Sing-a-Lung 2.0: protocol for a multicentre randomised controlled trial to investigate the effects and mechanisms of online-delivered singing training versus usual care 6-18 months after surgical resection for non-small cell lung cancer (NSCLC). BMJ Open Respir Res Kaasgaard M, Borg M, Hostrup M, Laursen CB, Land LH, Alstrup G, Nielsen AO, Kristensen JK, Naver MB, Hilberg O, Bodtger U. PMID: 42431709 [PubMed - in process]
	Inconsistent definitions of local control for stereotactic body radiation therapy for early-stage lung cancer - A systematic review. Radiother Oncol Nourmohammadi N, Kashani C, Oughourlian T, Nikitas J, Deng J, Lee A, Oh S, Bradley J, Guckenberger M, Siva S, Palma D, Yom SS, Senan S, Moghanaki D. PMID: 42431270 [PubMed - as supplied by publisher]
	Brief Report: First-line Chemoimmunotherapy and Chemotherapy Outcomes in Patients with RET Fusion-Positive Lung Cancer in LIBRETTO-431. J Thorac Oncol Cui C, Lin S, Waliany S, Lomibao M, Falcon C, Wilhelm C, Iasonos A, Lin JJ, Drilon A. PMID: 42431264 [PubMed - as supplied by publisher]
	Phase 3 Study of Niraparib-Plus-Pembrolizumab as Maintenance Therapy for Advanced/Metastatic Non-Small Cell Lung Cancer (ZEAL-1L). J Thorac Oncol Ramalingam SS, Velcheti V, Altan M, de Castro G Jr, Thomas M, Sanborn RE, Maziéres J, Schuler M, Isaksson J, Schenker M, Poddubskaya E, Kim YJ, Parakh S, Liu W, Neibauer MW, Aghera V, Chiu G, Peters S. PMID: 42431263 [PubMed - as supplied by publisher]

Articles 1 - 20 / 160406

Page 1 of 8021



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy